Grail’s reply to editorial on “liquid biopsy” for cancer screening
Automated next generation sequencing platform can accurately screen thousands for COVID-19
3 March 2021Single vaccine dose may offer protection to those who have had COVID-19
3 March 2021Grail’s reply to editorial on “liquid biopsy” for cancer screening
I write in response to some of the key points raised in Barclay and Bradley’s editorial regarding the partnership between Grail and NHS England.1Grail’s multi-cancer early detection (MCED) test…
